ChatGPT

Perplexity

Gemini

Claude

Grok

Living with kidney disease can feel overwhelming; you don’t have to do it alone. Learn more about kidney disease and lifestyle choices, and access robust nutrition and education tools to support your 

The DaVita Events app will host event information for DaVita's large gatherings. If applicable, this app will support event apps for Villagewide, Physician Leadership Meeting, and others.
The events a

DaVita’s HIPAA-compliant messaging tool supports rapid communication and cross-team collaboration. DaVita Secure Messaging is available for DaVita teammates and credentialed providers.
Why use secure 

Delivering the highest quality clinical care and service to kidney disease patients, with 25 years of leadership in clinical outcomes, quality metrics, and patient satisfaction across the dialysis industry.

Service Excellence

Operating with the highest ethical standards in patient care, business practices, and regulatory compliance, maintaining trust with patients, teammates, and the healthcare community despite facing legal and regulatory challenges.

Integrity

Fostering a village culture where teammates are empowered, valued, and supported in their mission to give life to patients, with emphasis on collaboration, shared purpose, and collective accountability.

Team

Pioneering advances in kidney care delivery including home dialysis growth (15% of patients in 2024), transplant facilitation (8,200 transplants in 2024), and integrated care models that improve patient outcomes and quality of life.

Innovation

Relentlessly pursuing better clinical outcomes, operational efficiency, and patient experiences through data-driven quality improvement programs, benchmarking, and implementation of best practices across the global network.

Continuous Improvement

DaVita is the leading kidney care provider in the United States, operating over 3,100 outpatient dialysis centers globally and serving approximately 265,000 patients with end-stage renal disease (ESRD) through clinical dialysis treatments, home dialysis programs, and integrated kidney care services with a mission 'to give life.'

Kidney dialysis co DaVita tells 2.4M they're in ransomware data theft nightmare

Venture fund NEA buys Davita's direct primary care biz for $100M

How comes a company like DaVita is legal in the US?

Javier J. Rodriguez

Chief Executive Officer & Director

Joel Ackerman

Chief Financial Officer & Treasurer

Madhu Narasimhan

Chief Information Officer

Kent J. Thiry

Former CEO & Executive Chairman (1999-2019)

DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the Fortune 500.

Comprehensive in-center hemodialysis treatments at 3,113 outpatient dialysis centers worldwide (2,660 in U.S., 453 internationally). Patients typically receive treatment three times per week for 3-4 hours per session, with clinical teams monitoring treatment efficacy, managing complications, and coordinating overall kidney care.

In-Center Hemodialysis

Home hemodialysis programs enabling patients to perform dialysis treatments at home with greater flexibility, convenience, and clinical benefits. In 2024, 15% of DaVita patients treated on a home modality, achieving double-digit growth in home dialysis treatments.

Home Hemodialysis Programs

Peritoneal dialysis services and training programs where patients use the lining of their abdomen (peritoneum) to filter waste from blood. This home-based treatment modality offers greater independence and is associated with improved quality of life.

Peritoneal Dialysis

Comprehensive kidney care services including chronic kidney disease (CKD) management, pre-dialysis education, vascular access care, medication management, nutritional counseling, and care coordination to optimize patient outcomes across the disease continuum.

Integrated Kidney Care

Kidney transplant facilitation and support services helping patients access transplant evaluation, navigate the transplant waitlist, identify living donors, and receive post-transplant care coordination. Helped 8,200 patients receive transplants in 2024, a company record.

Transplant Support Services

Specialized vascular access services including fistula and graft creation, catheter placement and maintenance, and vascular access monitoring to ensure reliable dialysis treatment delivery and minimize complications.

Vascular Access Management

Comprehensive clinical laboratory testing and monitoring services to track kidney function, mineral and bone disorder, anemia management, nutrition status, and treatment adequacy for optimal dialysis outcomes.

Clinical Laboratory Services

DaVita celebrated 25 years since forming with a purpose 'to give life' in 2000, highlighting a quarter-century of clinical care delivery, leadership in healthcare innovation, and commitment to improving clinical outcomes and quality of life for kidney disease patients worldwide.

DaVita Celebrates 25 Years of Exceptional Patient Care

DaVita reported Q4 2024 consolidated revenues of $3.295 billion and full-year 2024 revenues of $12.816 billion. Diluted EPS was $3.09 for Q4 and $10.73 for the full year. Operating income reached $565 million for Q4 and $2,090 million for the full year. The company returned $1.389 billion to stockholders via share repurchases, reducing shares outstanding by 9.3%.

DaVita Inc. Reports 4th Quarter 2024 Results with Strong Financial Performance

Nearly 8,200 DaVita patients received kidney transplants in 2024, the provider's highest number of annual transplants ever. This milestone demonstrates DaVita's commitment to supporting patients toward the best possible outcome and reflects the company's comprehensive transplant support programs.

DaVita Achieves Record Annual Kidney Transplants in 2024

DaVita reported Q1 2025 revenue of $3.22 billion and EPS of $2.00, both beating analyst forecasts despite headwinds from a cybersecurity incident that disrupted portions of operations and a severe flu season. The company maintained its 2025 guidance range for adjusted operating income and adjusted EPS.

DaVita Beats Q1 2025 EPS Forecast Despite Cybersecurity Incident

In 2024, 15% of DaVita patients were treated on a home modality (home hemodialysis or peritoneal dialysis), achieving double-digit home dialysis treatment growth. Home dialysis offers improved quality of life and clinical outcomes compared to in-center treatment.

DaVita Reaches 15% Home Dialysis Rate with Double-Digit Growth

In May 2025, the United Food and Commercial Workers Local 1776 benefits fund filed a proposed class-action lawsuit against DaVita and Fresenius Medical Care, alleging the two companies illegally conspired to inflate treatment costs for dialysis patients by billions of dollars. This follows a 2024 FTC investigation into alleged anticompetitive tactics.

FTC and Class-Action Lawsuit Allege DaVita-Fresenius Anticompetitive Practices

CEO Javier Rodriguez outlined DaVita's 2025 strategy, projecting flat treatment volumes, 5% revenue per treatment growth, and 6-7% cost per treatment growth. He emphasized continued focus on clinical excellence, home dialysis expansion, transplant facilitation, and operational efficiency improvements.

DaVita CEO Rodriguez Discusses 2025 Strategy and Future of Kidney Care

Nearly a million patients hit by DaVita dialysis ransomware attack

Dialysis Nurse at Davita

Davita social workers

DaVita

Davita rd

RN considering DaVita… concerns about schedule &amp; being charge right away?

Is working as an FA for davita bad for work life balance?

Fired from Davita

nursing

dietetics

technology

socialwork

NoStupidQuestions

dialysis

DAVITA INC.

Services-Misc Health & Allied Services, NEC

The company was originally established as Medical Ambulatory Care, Inc., providing medical services in ambulatory settings, which would eventually evolve into kidney dialysis services.

Company Founded as Medical Ambulatory Care

The company was formally reorganized as Total Renal Care, Inc., establishing its focused mission as a kidney dialysis provider during a period of industry consolidation.

Reorganized as Total Renal Care

Kent J. Thiry, age 43, was named CEO after the company faced near-bankruptcy due to aggressive debt-fueled expansion and failed acquisitions. This marked the beginning of a remarkable 20-year turnaround.

Kent Thiry Named CEO During Crisis

More than 600 company leaders gathered to vote on the new name DaVita (from Italian "Dare Vita" meaning "to give life") and to establish the company's Core Values that would guide its transformation.

Leadership Vote on New Name and Values

Total Renal Care was officially renamed DaVita Inc., symbolizing the company's cultural and operational transformation with a mission focused on giving life to kidney disease patients.

Rebranded as DaVita Inc.

At the first national Villagewide meeting, "The DaVita Way" was introduced, establishing the cultural framework and values-driven approach that would define the company's operations and identity.

The DaVita Way Introduced

DaVita acquired Gambro Healthcare, doubling its number of dialysis centers and symbolizing the capstone of its remarkable turnaround from near-bankruptcy to industry leader.

Gambro Healthcare Acquisition

DaVita acquired Healthcare Partners for $4.42 billion, significantly expanding into integrated care delivery and physician practice management beyond dialysis services.

Healthcare Partners Acquisition

The company agreed to pay $350 million to settle federal claims that it provided illegal kickbacks to doctors, highlighting regulatory and compliance challenges in the dialysis industry.

Kickback Settlement - $350M

DaVita agreed to pay $450 million to settle allegations that it unnecessarily disposed of drugs and then billed the federal government for waste, marking another significant regulatory settlement.

Drug Waste Settlement - $450M

The Healthcare Partners division was rebranded as DaVita Medical Group, integrating the physician practice and managed care operations more closely with the DaVita brand.

Healthcare Partners Renamed DaVita Medical Group

After nearly 20 years of transformative leadership, Kent Thiry transitioned to Executive Chairman as Javier Rodriguez became CEO. Simultaneously, DaVita sold the DaVita Medical Group division to UnitedHealth Group's Optum for $4.3 billion, refocusing on core kidney care.

Leadership Transition and Medical Group Sale

Nearly 8,200 DaVita patients received kidney transplants in 2024, the provider's highest number of annual transplants ever, demonstrating commitment to the best patient outcomes.

Record Annual Kidney Transplants

DaVita celebrated 25 years since the 2000 rebranding and cultural transformation, marking a quarter-century of exceptional patient care, clinical innovation, and empowering the future of kidney health.

25th Anniversary Celebration

Turn your phone into a powerful payment terminal. Accept donations, sell tickets and track all payments instantly — no extra hardware needed!

With the Zeffy app, your nonprofit can:
• Accept all majo

DaVita vs Zeffy

DaVita

About

Zeffy

About

AI Visibility Head-to-Head

Also Compare

Track AI Visibility in Real Time